___

• Cottler-Fox M, Lapidot T, Petit I, et al. Stem cell
• mobilization. Hematology 2003;419-437.
• Lee JL, Kim SB, Lee GW, et al. Clinical
• usefulness of the hematopoietic progenitor cell
• counts in predicting the optimal timing of
• peripheral blood stem cell harvest. J Korean
• Med Sci 2003; 18: 27-35. doi: 10.1111/j.0041-
• 2004.04166.x
• Rainer Moog. Management strategies for poor
• peripheral blood stem cell mobilization. Transfus
• Apher Sci. 2008; 38: 229–236. doi:
• 1016/j.transci.2008.04.002
• Mendrone A Jr, Arrais CA, Saboya R, Chamone
• DA, Frederico Luiz Dulley FL. Factors affecting
• hematopoietic progenitor cell mobilization: An
• analysis of 307 patients. Transfus Apher Sci.
• ; 39: 187–192. doi:
• 1016/j.transci.2008.09.012
• Arslan O, Moog R. Mobilization of peripheral
• blood stem cells. Transfusion and Apheresis
• Science 2007; 37: 179–185. doi:
• 1016/j.transci.2007.08.002
• Weaver CH, Schwartzberg LS, Birch R, et al.
• Collection of peripheral blood progenitor cells
• after the administration of cyclophosphamide,
• etoposide, and granulocyte-colony-stimulating
• factor: an analysis of 497 patients. Transfusion
• ;37:896–903. doi:10.1046/j.1537-
• 1997.37997454014.x
• Haas R, Möhle R, Frühauf S, et al. Patient
• characteristics associated with successful
• mobilizing and autografting of peripheral
• progenitor cells in malignant lymphoma. Blood
• ;83:3787–3794.
• Kasparu H, Krieger O, Girschikofsky M, Kolb A,
• Bettelheim P, Lutz D. Factors influencing the
• timing of peripheral blood stem cell collection
• (PBSC). Transfus Apheresis Sci 1996;17:595–
• -
• Ikeda K, Kozuka T, Harada M. Factors for PBPC
• collection efficiency and collection predictors.
• Transfus Apher Sci. 2004;31: 245–259. doi:
• 1016/j.transci.2004.09.008
• Elliott C, Samson DM, Armitage S, et al. When
• to harvest peripheral-blood stem cells after
• mobilization therapy: Prediction of CD34-positive
• cell yield by preceding day CD34-positive
• concentration in peripheral blood. J Clin Oncol
• ; 14:970-973.
• Gidron A, Singh V, Egan K, Mehta J.
• Significance of low peripheral blood CD34ş cell
• numbers prior to leukapheresis: what should the
• threshold required for apheresis be? Bone
• Marrow Transplant 2008; 42: 439–442.
• Mehta J, Oyama Y, Winter J, et al. CD34+ cell
• collection efficiency does not correlate with the
• pre-leukapheresis hematocrit. Bone Marrow
• Transplant 2001; 28: 597–601.
• Gidron A, Verma A, Doyle M, et al. Can the stem
• cell mobilization technique influence CD34+ cell
• collection efficiency of leukapheresis procedures
• in patients with hematologic malignancies? Bone
• Marrow Transplant 2005; 35: 243–246. doi:
• 1038/sj.bmt.1704781
• Schots R, Van Riet I, Damianos S, et al. The
• absolute number of circulating CD34+ cells
• predicts the number of hematopoietic stem cells
• that can be predicted by apheresis. Bone
• Marrow Transplant 1996;17:509-15.
• Schwella N, Beyer J, Schwaner I, et al. Impact of
• preleukapheresis cell counts on collection
• results and correlation of progenitor cell dose
• with engraftment after high-dose chemotherapy
• in patients with germ-cell cancer. J Clin Oncol
• ;14:1114-1121.
• Mohle R, Murea S, Pforsich M, Witt B, Haas R.
• Estimation of the progenitor cell yield in a
• leukapheresis product by previous measurement
• of CD34+ cells in the peripheral blood. Vox Sang
• ;71:90-196.
• I. KAYGUSUZ, et al
• Factors affecting stem cell mobilization
• Marmara Medical Journal 2011; 24 (1):31-37
• -
• Ford C, Chan K, Reilly W, Peterson F. An
• evaluation of predictive factors for CD34+ cell
• harvest yields from patients mobilized with
• chemotherapy and growth factors. Transfusion
• ;43:622-625. doi: 10.1046/j.1537-
• 2003.00376.x
• Moncada V, Bolan C, Yau Y, Leitman S.
• Analysis of PBPC yields during large volume
• leukapheresis of subjects with a poor
• mobilization response to filgrastim. Transfusion
• ;43:495-501. doi: 10.1046/j.1537-
• 2003.00361.x
• Ravagnani F, Siena S, De Reys S, et al.
• Improved collection of mobilized CD34+
• hematopoietic progenitor cells by a novel
• automated leukapheresis system. Transfusion
• ;39:48–55. doi: 10.1046/j.1537-
• 1999.39199116894.x
• Bambi F, Faulkner LB, Azzari C, et al. Pediatric
• peripheral blood progenitor cell collection:
• haemonetics MCS 3P versus COBE Spectra
• versus Fresenius AS104. Transfusion 1998
• Jan;38(1):70-74.
• Kishita M. Stability of granulocyte colonystimulating
• factor (G-CSF) in serum. Clin Rep
• ;26:221–224.
• Pedrazzoli P, Gibelli N, Pavesi L, et al. Effects of
• glycosylated and non-glycosylated G-CSFs,
• alone and in combination with other cytokines,
• on the growth of human progenitor cells.
• Anticancer Res 1996;16:1781–1785.
• Mire-Sluis AR, Das RG, Thorpe R. The
• international standard for granulocyte colony
• stimulating factor (G-CSF). Evaluation in an
• international collaborative study. Participants of
• the Collaborative Study. J Immunol Methods
• ;179:117–126.
• Nissen C, dalle Carbonare Y, Moser Y. In vitro
• comparison of the biological potency of
• glycosylated versus non-glycosylated rG-CSF.
• Drug Invest 1994;7:346–352.
• Höglund M, Smedmyr B, Bengtsson M, et al.
• Mobilization of CD34+ cells by glycosylated and
• nonglycosylated G-CSF in healthy donors –
• comparative study. Eur J Haematol
• ;59:177–183. doi: 10.1111/j.1600-
• 1997.tb00972.x
• Watts MJ, Addison I, Long SG, et al. Crossover
• study of the haematological effects and
• pharmacokinetics of glycosylated and nonglycosylated
• G-CSF in healthy volunteers. Br J
• Haematol 1997;98:474–479. doi:
• 1046/j.1365-2141.1997.2393053
• Schiødt I, Knudsen LM, Jensen L, et al. Flow
• cytometry comparison of CD341 subsets in bone
• marrow and peripheral blood after priming with
• glycosylated or non-glycosylated rhG-CSF. Bone
• Marrow Transplant 1998; 21:1167–1169.
• Tomblyn M, Burns LJ, Blazar B, et al. Difficult
• stem cell mobilization despite adequate CD34+
• cell dose predicts shortened progression free
• and overall survival after autologous HSCT for
• lymphoma. Bone Marrow Transplant 2007;
• :111–118. doi: 10.1038/sj.bmt.1705708
• Dreger P, Kloss M, Petersen B, et al. Autologous
• progenitor cell transplantation: Prior exposure to
• stem cell-toxic drugs determines yield and
• engraftment of peripheral blood progenitor cell
• but not of bone marrow grafts. Blood 1995;
• (10): 3970-3978.